EARLYBIO

Siemens researcher and privat investors founded EarlyBio in 2017 to acquire patents and rights on the Magnetic Flow Cytometry technology. The buy-out permits EarlyBio the development and global commercialization of eCyto cell function tests for the point-of-care. EarlyBio will provide functional single cell information to support clinical decision making in critical-care environments. To date, EarlyBio has raised a seed financing round... We are honoured to be recipients of the Innovation Award of the AMA Association of Sensor and Measurement for the scientific achievement and market relevance of the eCyto technology... EarlyBio develops the technology platform eCyto for bedside testing of early and non-stable biomarkers

Also known as: Earlybio gmbh

Registration numbers: HRB 185419 B (W)

Primary location: Berlin Germany